Medical Care
Global NanoBioTechnology (NBT) Market Research Report 2025
- Jul 08, 25
- ID: 349051
- Pages: 75
- Figures: 80
- Views: 10
The global market for NanoBioTechnology (NBT) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Nano biotechnology combines nano technology and biotechnology including special physicochemical and biological properties of nanostructures and their applications in numerous fieldslike medicine and agriculture. Nanobiotechnology is one of the most promising technologies in the 21st century. It plays a major role in developing and implementing many useful tools in the study of life. Its application in medicine involves disease diagnosis, target-specific drug delivery and molecular imaging. It also has application in agriculture and food. The factors such as increasing demand for the innovative drug in the pharmaceutical industry, rise in the application of nano biotechnology electronics, energy production and biomaterials and increased research & development investment are the key drivers of the global nano biotechnology market.
North American market for NanoBioTechnology (NBT) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for NanoBioTechnology (NBT) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for NanoBioTechnology (NBT) in Pharmaceuticals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of NanoBioTechnology (NBT) include Ablynx (Belgium), Nami Therapeutics (US), Celgene Corporation (US), Nanophase Technologies Corporation (US), Sigma-Aldrich (US), SkyePharma Pharmaceuticals (France), Nano Bridging Molecules SA (Switzerland), XanTecbioanalytics GmbH (Germany), Nanobiotix(France), Dabur Pharma (India), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for NanoBioTechnology (NBT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NanoBioTechnology (NBT).
The NanoBioTechnology (NBT) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NanoBioTechnology (NBT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NanoBioTechnology (NBT) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ablynx (Belgium)
Nami Therapeutics (US)
Celgene Corporation (US)
Nanophase Technologies Corporation (US)
Sigma-Aldrich (US)
SkyePharma Pharmaceuticals (France)
Nano Bridging Molecules SA (Switzerland)
XanTecbioanalytics GmbH (Germany)
Nanobiotix(France)
Dabur Pharma (India)
Segment by Type
0-10 nm
10-100 nm
Segment by Application
Pharmaceuticals
Medical Research
Food and Agriculture
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NanoBioTechnology (NBT) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Nano biotechnology combines nano technology and biotechnology including special physicochemical and biological properties of nanostructures and their applications in numerous fieldslike medicine and agriculture. Nanobiotechnology is one of the most promising technologies in the 21st century. It plays a major role in developing and implementing many useful tools in the study of life. Its application in medicine involves disease diagnosis, target-specific drug delivery and molecular imaging. It also has application in agriculture and food. The factors such as increasing demand for the innovative drug in the pharmaceutical industry, rise in the application of nano biotechnology electronics, energy production and biomaterials and increased research & development investment are the key drivers of the global nano biotechnology market.
North American market for NanoBioTechnology (NBT) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for NanoBioTechnology (NBT) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for NanoBioTechnology (NBT) in Pharmaceuticals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of NanoBioTechnology (NBT) include Ablynx (Belgium), Nami Therapeutics (US), Celgene Corporation (US), Nanophase Technologies Corporation (US), Sigma-Aldrich (US), SkyePharma Pharmaceuticals (France), Nano Bridging Molecules SA (Switzerland), XanTecbioanalytics GmbH (Germany), Nanobiotix(France), Dabur Pharma (India), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for NanoBioTechnology (NBT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NanoBioTechnology (NBT).
The NanoBioTechnology (NBT) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NanoBioTechnology (NBT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NanoBioTechnology (NBT) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ablynx (Belgium)
Nami Therapeutics (US)
Celgene Corporation (US)
Nanophase Technologies Corporation (US)
Sigma-Aldrich (US)
SkyePharma Pharmaceuticals (France)
Nano Bridging Molecules SA (Switzerland)
XanTecbioanalytics GmbH (Germany)
Nanobiotix(France)
Dabur Pharma (India)
Segment by Type
0-10 nm
10-100 nm
Segment by Application
Pharmaceuticals
Medical Research
Food and Agriculture
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NanoBioTechnology (NBT) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NanoBioTechnology (NBT) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 0-10 nm
1.2.3 10-100 nm
1.3 Market by Application
1.3.1 Global NanoBioTechnology (NBT) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceuticals
1.3.3 Medical Research
1.3.4 Food and Agriculture
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NanoBioTechnology (NBT) Market Perspective (2020-2031)
2.2 Global NanoBioTechnology (NBT) Growth Trends by Region
2.2.1 Global NanoBioTechnology (NBT) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 NanoBioTechnology (NBT) Historic Market Size by Region (2020-2025)
2.2.3 NanoBioTechnology (NBT) Forecasted Market Size by Region (2026-2031)
2.3 NanoBioTechnology (NBT) Market Dynamics
2.3.1 NanoBioTechnology (NBT) Industry Trends
2.3.2 NanoBioTechnology (NBT) Market Drivers
2.3.3 NanoBioTechnology (NBT) Market Challenges
2.3.4 NanoBioTechnology (NBT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NanoBioTechnology (NBT) Players by Revenue
3.1.1 Global Top NanoBioTechnology (NBT) Players by Revenue (2020-2025)
3.1.2 Global NanoBioTechnology (NBT) Revenue Market Share by Players (2020-2025)
3.2 Global NanoBioTechnology (NBT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by NanoBioTechnology (NBT) Revenue
3.4 Global NanoBioTechnology (NBT) Market Concentration Ratio
3.4.1 Global NanoBioTechnology (NBT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NanoBioTechnology (NBT) Revenue in 2024
3.5 Global Key Players of NanoBioTechnology (NBT) Head office and Area Served
3.6 Global Key Players of NanoBioTechnology (NBT), Product and Application
3.7 Global Key Players of NanoBioTechnology (NBT), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 NanoBioTechnology (NBT) Breakdown Data by Type
4.1 Global NanoBioTechnology (NBT) Historic Market Size by Type (2020-2025)
4.2 Global NanoBioTechnology (NBT) Forecasted Market Size by Type (2026-2031)
5 NanoBioTechnology (NBT) Breakdown Data by Application
5.1 Global NanoBioTechnology (NBT) Historic Market Size by Application (2020-2025)
5.2 Global NanoBioTechnology (NBT) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America NanoBioTechnology (NBT) Market Size (2020-2031)
6.2 North America NanoBioTechnology (NBT) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America NanoBioTechnology (NBT) Market Size by Country (2020-2025)
6.4 North America NanoBioTechnology (NBT) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NanoBioTechnology (NBT) Market Size (2020-2031)
7.2 Europe NanoBioTechnology (NBT) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe NanoBioTechnology (NBT) Market Size by Country (2020-2025)
7.4 Europe NanoBioTechnology (NBT) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NanoBioTechnology (NBT) Market Size (2020-2031)
8.2 Asia-Pacific NanoBioTechnology (NBT) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific NanoBioTechnology (NBT) Market Size by Region (2020-2025)
8.4 Asia-Pacific NanoBioTechnology (NBT) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NanoBioTechnology (NBT) Market Size (2020-2031)
9.2 Latin America NanoBioTechnology (NBT) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America NanoBioTechnology (NBT) Market Size by Country (2020-2025)
9.4 Latin America NanoBioTechnology (NBT) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NanoBioTechnology (NBT) Market Size (2020-2031)
10.2 Middle East & Africa NanoBioTechnology (NBT) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa NanoBioTechnology (NBT) Market Size by Country (2020-2025)
10.4 Middle East & Africa NanoBioTechnology (NBT) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ablynx (Belgium)
11.1.1 Ablynx (Belgium) Company Details
11.1.2 Ablynx (Belgium) Business Overview
11.1.3 Ablynx (Belgium) NanoBioTechnology (NBT) Introduction
11.1.4 Ablynx (Belgium) Revenue in NanoBioTechnology (NBT) Business (2020-2025)
11.1.5 Ablynx (Belgium) Recent Development
11.2 Nami Therapeutics (US)
11.2.1 Nami Therapeutics (US) Company Details
11.2.2 Nami Therapeutics (US) Business Overview
11.2.3 Nami Therapeutics (US) NanoBioTechnology (NBT) Introduction
11.2.4 Nami Therapeutics (US) Revenue in NanoBioTechnology (NBT) Business (2020-2025)
11.2.5 Nami Therapeutics (US) Recent Development
11.3 Celgene Corporation (US)
11.3.1 Celgene Corporation (US) Company Details
11.3.2 Celgene Corporation (US) Business Overview
11.3.3 Celgene Corporation (US) NanoBioTechnology (NBT) Introduction
11.3.4 Celgene Corporation (US) Revenue in NanoBioTechnology (NBT) Business (2020-2025)
11.3.5 Celgene Corporation (US) Recent Development
11.4 Nanophase Technologies Corporation (US)
11.4.1 Nanophase Technologies Corporation (US) Company Details
11.4.2 Nanophase Technologies Corporation (US) Business Overview
11.4.3 Nanophase Technologies Corporation (US) NanoBioTechnology (NBT) Introduction
11.4.4 Nanophase Technologies Corporation (US) Revenue in NanoBioTechnology (NBT) Business (2020-2025)
11.4.5 Nanophase Technologies Corporation (US) Recent Development
11.5 Sigma-Aldrich (US)
11.5.1 Sigma-Aldrich (US) Company Details
11.5.2 Sigma-Aldrich (US) Business Overview
11.5.3 Sigma-Aldrich (US) NanoBioTechnology (NBT) Introduction
11.5.4 Sigma-Aldrich (US) Revenue in NanoBioTechnology (NBT) Business (2020-2025)
11.5.5 Sigma-Aldrich (US) Recent Development
11.6 SkyePharma Pharmaceuticals (France)
11.6.1 SkyePharma Pharmaceuticals (France) Company Details
11.6.2 SkyePharma Pharmaceuticals (France) Business Overview
11.6.3 SkyePharma Pharmaceuticals (France) NanoBioTechnology (NBT) Introduction
11.6.4 SkyePharma Pharmaceuticals (France) Revenue in NanoBioTechnology (NBT) Business (2020-2025)
11.6.5 SkyePharma Pharmaceuticals (France) Recent Development
11.7 Nano Bridging Molecules SA (Switzerland)
11.7.1 Nano Bridging Molecules SA (Switzerland) Company Details
11.7.2 Nano Bridging Molecules SA (Switzerland) Business Overview
11.7.3 Nano Bridging Molecules SA (Switzerland) NanoBioTechnology (NBT) Introduction
11.7.4 Nano Bridging Molecules SA (Switzerland) Revenue in NanoBioTechnology (NBT) Business (2020-2025)
11.7.5 Nano Bridging Molecules SA (Switzerland) Recent Development
11.8 XanTecbioanalytics GmbH (Germany)
11.8.1 XanTecbioanalytics GmbH (Germany) Company Details
11.8.2 XanTecbioanalytics GmbH (Germany) Business Overview
11.8.3 XanTecbioanalytics GmbH (Germany) NanoBioTechnology (NBT) Introduction
11.8.4 XanTecbioanalytics GmbH (Germany) Revenue in NanoBioTechnology (NBT) Business (2020-2025)
11.8.5 XanTecbioanalytics GmbH (Germany) Recent Development
11.9 Nanobiotix(France)
11.9.1 Nanobiotix(France) Company Details
11.9.2 Nanobiotix(France) Business Overview
11.9.3 Nanobiotix(France) NanoBioTechnology (NBT) Introduction
11.9.4 Nanobiotix(France) Revenue in NanoBioTechnology (NBT) Business (2020-2025)
11.9.5 Nanobiotix(France) Recent Development
11.10 Dabur Pharma (India)
11.10.1 Dabur Pharma (India) Company Details
11.10.2 Dabur Pharma (India) Business Overview
11.10.3 Dabur Pharma (India) NanoBioTechnology (NBT) Introduction
11.10.4 Dabur Pharma (India) Revenue in NanoBioTechnology (NBT) Business (2020-2025)
11.10.5 Dabur Pharma (India) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NanoBioTechnology (NBT) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 0-10 nm
1.2.3 10-100 nm
1.3 Market by Application
1.3.1 Global NanoBioTechnology (NBT) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceuticals
1.3.3 Medical Research
1.3.4 Food and Agriculture
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NanoBioTechnology (NBT) Market Perspective (2020-2031)
2.2 Global NanoBioTechnology (NBT) Growth Trends by Region
2.2.1 Global NanoBioTechnology (NBT) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 NanoBioTechnology (NBT) Historic Market Size by Region (2020-2025)
2.2.3 NanoBioTechnology (NBT) Forecasted Market Size by Region (2026-2031)
2.3 NanoBioTechnology (NBT) Market Dynamics
2.3.1 NanoBioTechnology (NBT) Industry Trends
2.3.2 NanoBioTechnology (NBT) Market Drivers
2.3.3 NanoBioTechnology (NBT) Market Challenges
2.3.4 NanoBioTechnology (NBT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NanoBioTechnology (NBT) Players by Revenue
3.1.1 Global Top NanoBioTechnology (NBT) Players by Revenue (2020-2025)
3.1.2 Global NanoBioTechnology (NBT) Revenue Market Share by Players (2020-2025)
3.2 Global NanoBioTechnology (NBT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by NanoBioTechnology (NBT) Revenue
3.4 Global NanoBioTechnology (NBT) Market Concentration Ratio
3.4.1 Global NanoBioTechnology (NBT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NanoBioTechnology (NBT) Revenue in 2024
3.5 Global Key Players of NanoBioTechnology (NBT) Head office and Area Served
3.6 Global Key Players of NanoBioTechnology (NBT), Product and Application
3.7 Global Key Players of NanoBioTechnology (NBT), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 NanoBioTechnology (NBT) Breakdown Data by Type
4.1 Global NanoBioTechnology (NBT) Historic Market Size by Type (2020-2025)
4.2 Global NanoBioTechnology (NBT) Forecasted Market Size by Type (2026-2031)
5 NanoBioTechnology (NBT) Breakdown Data by Application
5.1 Global NanoBioTechnology (NBT) Historic Market Size by Application (2020-2025)
5.2 Global NanoBioTechnology (NBT) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America NanoBioTechnology (NBT) Market Size (2020-2031)
6.2 North America NanoBioTechnology (NBT) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America NanoBioTechnology (NBT) Market Size by Country (2020-2025)
6.4 North America NanoBioTechnology (NBT) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NanoBioTechnology (NBT) Market Size (2020-2031)
7.2 Europe NanoBioTechnology (NBT) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe NanoBioTechnology (NBT) Market Size by Country (2020-2025)
7.4 Europe NanoBioTechnology (NBT) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NanoBioTechnology (NBT) Market Size (2020-2031)
8.2 Asia-Pacific NanoBioTechnology (NBT) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific NanoBioTechnology (NBT) Market Size by Region (2020-2025)
8.4 Asia-Pacific NanoBioTechnology (NBT) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NanoBioTechnology (NBT) Market Size (2020-2031)
9.2 Latin America NanoBioTechnology (NBT) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America NanoBioTechnology (NBT) Market Size by Country (2020-2025)
9.4 Latin America NanoBioTechnology (NBT) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NanoBioTechnology (NBT) Market Size (2020-2031)
10.2 Middle East & Africa NanoBioTechnology (NBT) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa NanoBioTechnology (NBT) Market Size by Country (2020-2025)
10.4 Middle East & Africa NanoBioTechnology (NBT) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ablynx (Belgium)
11.1.1 Ablynx (Belgium) Company Details
11.1.2 Ablynx (Belgium) Business Overview
11.1.3 Ablynx (Belgium) NanoBioTechnology (NBT) Introduction
11.1.4 Ablynx (Belgium) Revenue in NanoBioTechnology (NBT) Business (2020-2025)
11.1.5 Ablynx (Belgium) Recent Development
11.2 Nami Therapeutics (US)
11.2.1 Nami Therapeutics (US) Company Details
11.2.2 Nami Therapeutics (US) Business Overview
11.2.3 Nami Therapeutics (US) NanoBioTechnology (NBT) Introduction
11.2.4 Nami Therapeutics (US) Revenue in NanoBioTechnology (NBT) Business (2020-2025)
11.2.5 Nami Therapeutics (US) Recent Development
11.3 Celgene Corporation (US)
11.3.1 Celgene Corporation (US) Company Details
11.3.2 Celgene Corporation (US) Business Overview
11.3.3 Celgene Corporation (US) NanoBioTechnology (NBT) Introduction
11.3.4 Celgene Corporation (US) Revenue in NanoBioTechnology (NBT) Business (2020-2025)
11.3.5 Celgene Corporation (US) Recent Development
11.4 Nanophase Technologies Corporation (US)
11.4.1 Nanophase Technologies Corporation (US) Company Details
11.4.2 Nanophase Technologies Corporation (US) Business Overview
11.4.3 Nanophase Technologies Corporation (US) NanoBioTechnology (NBT) Introduction
11.4.4 Nanophase Technologies Corporation (US) Revenue in NanoBioTechnology (NBT) Business (2020-2025)
11.4.5 Nanophase Technologies Corporation (US) Recent Development
11.5 Sigma-Aldrich (US)
11.5.1 Sigma-Aldrich (US) Company Details
11.5.2 Sigma-Aldrich (US) Business Overview
11.5.3 Sigma-Aldrich (US) NanoBioTechnology (NBT) Introduction
11.5.4 Sigma-Aldrich (US) Revenue in NanoBioTechnology (NBT) Business (2020-2025)
11.5.5 Sigma-Aldrich (US) Recent Development
11.6 SkyePharma Pharmaceuticals (France)
11.6.1 SkyePharma Pharmaceuticals (France) Company Details
11.6.2 SkyePharma Pharmaceuticals (France) Business Overview
11.6.3 SkyePharma Pharmaceuticals (France) NanoBioTechnology (NBT) Introduction
11.6.4 SkyePharma Pharmaceuticals (France) Revenue in NanoBioTechnology (NBT) Business (2020-2025)
11.6.5 SkyePharma Pharmaceuticals (France) Recent Development
11.7 Nano Bridging Molecules SA (Switzerland)
11.7.1 Nano Bridging Molecules SA (Switzerland) Company Details
11.7.2 Nano Bridging Molecules SA (Switzerland) Business Overview
11.7.3 Nano Bridging Molecules SA (Switzerland) NanoBioTechnology (NBT) Introduction
11.7.4 Nano Bridging Molecules SA (Switzerland) Revenue in NanoBioTechnology (NBT) Business (2020-2025)
11.7.5 Nano Bridging Molecules SA (Switzerland) Recent Development
11.8 XanTecbioanalytics GmbH (Germany)
11.8.1 XanTecbioanalytics GmbH (Germany) Company Details
11.8.2 XanTecbioanalytics GmbH (Germany) Business Overview
11.8.3 XanTecbioanalytics GmbH (Germany) NanoBioTechnology (NBT) Introduction
11.8.4 XanTecbioanalytics GmbH (Germany) Revenue in NanoBioTechnology (NBT) Business (2020-2025)
11.8.5 XanTecbioanalytics GmbH (Germany) Recent Development
11.9 Nanobiotix(France)
11.9.1 Nanobiotix(France) Company Details
11.9.2 Nanobiotix(France) Business Overview
11.9.3 Nanobiotix(France) NanoBioTechnology (NBT) Introduction
11.9.4 Nanobiotix(France) Revenue in NanoBioTechnology (NBT) Business (2020-2025)
11.9.5 Nanobiotix(France) Recent Development
11.10 Dabur Pharma (India)
11.10.1 Dabur Pharma (India) Company Details
11.10.2 Dabur Pharma (India) Business Overview
11.10.3 Dabur Pharma (India) NanoBioTechnology (NBT) Introduction
11.10.4 Dabur Pharma (India) Revenue in NanoBioTechnology (NBT) Business (2020-2025)
11.10.5 Dabur Pharma (India) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global NanoBioTechnology (NBT) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of 0-10 nm
Table 3. Key Players of 10-100 nm
Table 4. Global NanoBioTechnology (NBT) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global NanoBioTechnology (NBT) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global NanoBioTechnology (NBT) Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global NanoBioTechnology (NBT) Market Share by Region (2020-2025)
Table 8. Global NanoBioTechnology (NBT) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global NanoBioTechnology (NBT) Market Share by Region (2026-2031)
Table 10. NanoBioTechnology (NBT) Market Trends
Table 11. NanoBioTechnology (NBT) Market Drivers
Table 12. NanoBioTechnology (NBT) Market Challenges
Table 13. NanoBioTechnology (NBT) Market Restraints
Table 14. Global NanoBioTechnology (NBT) Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global NanoBioTechnology (NBT) Market Share by Players (2020-2025)
Table 16. Global Top NanoBioTechnology (NBT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NanoBioTechnology (NBT) as of 2024)
Table 17. Ranking of Global Top NanoBioTechnology (NBT) Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by NanoBioTechnology (NBT) Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of NanoBioTechnology (NBT), Headquarters and Area Served
Table 20. Global Key Players of NanoBioTechnology (NBT), Product and Application
Table 21. Global Key Players of NanoBioTechnology (NBT), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global NanoBioTechnology (NBT) Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global NanoBioTechnology (NBT) Revenue Market Share by Type (2020-2025)
Table 25. Global NanoBioTechnology (NBT) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global NanoBioTechnology (NBT) Revenue Market Share by Type (2026-2031)
Table 27. Global NanoBioTechnology (NBT) Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global NanoBioTechnology (NBT) Revenue Market Share by Application (2020-2025)
Table 29. Global NanoBioTechnology (NBT) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global NanoBioTechnology (NBT) Revenue Market Share by Application (2026-2031)
Table 31. North America NanoBioTechnology (NBT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America NanoBioTechnology (NBT) Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America NanoBioTechnology (NBT) Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe NanoBioTechnology (NBT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe NanoBioTechnology (NBT) Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe NanoBioTechnology (NBT) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific NanoBioTechnology (NBT) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific NanoBioTechnology (NBT) Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific NanoBioTechnology (NBT) Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America NanoBioTechnology (NBT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America NanoBioTechnology (NBT) Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America NanoBioTechnology (NBT) Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa NanoBioTechnology (NBT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa NanoBioTechnology (NBT) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa NanoBioTechnology (NBT) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Ablynx (Belgium) Company Details
Table 47. Ablynx (Belgium) Business Overview
Table 48. Ablynx (Belgium) NanoBioTechnology (NBT) Product
Table 49. Ablynx (Belgium) Revenue in NanoBioTechnology (NBT) Business (2020-2025) & (US$ Million)
Table 50. Ablynx (Belgium) Recent Development
Table 51. Nami Therapeutics (US) Company Details
Table 52. Nami Therapeutics (US) Business Overview
Table 53. Nami Therapeutics (US) NanoBioTechnology (NBT) Product
Table 54. Nami Therapeutics (US) Revenue in NanoBioTechnology (NBT) Business (2020-2025) & (US$ Million)
Table 55. Nami Therapeutics (US) Recent Development
Table 56. Celgene Corporation (US) Company Details
Table 57. Celgene Corporation (US) Business Overview
Table 58. Celgene Corporation (US) NanoBioTechnology (NBT) Product
Table 59. Celgene Corporation (US) Revenue in NanoBioTechnology (NBT) Business (2020-2025) & (US$ Million)
Table 60. Celgene Corporation (US) Recent Development
Table 61. Nanophase Technologies Corporation (US) Company Details
Table 62. Nanophase Technologies Corporation (US) Business Overview
Table 63. Nanophase Technologies Corporation (US) NanoBioTechnology (NBT) Product
Table 64. Nanophase Technologies Corporation (US) Revenue in NanoBioTechnology (NBT) Business (2020-2025) & (US$ Million)
Table 65. Nanophase Technologies Corporation (US) Recent Development
Table 66. Sigma-Aldrich (US) Company Details
Table 67. Sigma-Aldrich (US) Business Overview
Table 68. Sigma-Aldrich (US) NanoBioTechnology (NBT) Product
Table 69. Sigma-Aldrich (US) Revenue in NanoBioTechnology (NBT) Business (2020-2025) & (US$ Million)
Table 70. Sigma-Aldrich (US) Recent Development
Table 71. SkyePharma Pharmaceuticals (France) Company Details
Table 72. SkyePharma Pharmaceuticals (France) Business Overview
Table 73. SkyePharma Pharmaceuticals (France) NanoBioTechnology (NBT) Product
Table 74. SkyePharma Pharmaceuticals (France) Revenue in NanoBioTechnology (NBT) Business (2020-2025) & (US$ Million)
Table 75. SkyePharma Pharmaceuticals (France) Recent Development
Table 76. Nano Bridging Molecules SA (Switzerland) Company Details
Table 77. Nano Bridging Molecules SA (Switzerland) Business Overview
Table 78. Nano Bridging Molecules SA (Switzerland) NanoBioTechnology (NBT) Product
Table 79. Nano Bridging Molecules SA (Switzerland) Revenue in NanoBioTechnology (NBT) Business (2020-2025) & (US$ Million)
Table 80. Nano Bridging Molecules SA (Switzerland) Recent Development
Table 81. XanTecbioanalytics GmbH (Germany) Company Details
Table 82. XanTecbioanalytics GmbH (Germany) Business Overview
Table 83. XanTecbioanalytics GmbH (Germany) NanoBioTechnology (NBT) Product
Table 84. XanTecbioanalytics GmbH (Germany) Revenue in NanoBioTechnology (NBT) Business (2020-2025) & (US$ Million)
Table 85. XanTecbioanalytics GmbH (Germany) Recent Development
Table 86. Nanobiotix(France) Company Details
Table 87. Nanobiotix(France) Business Overview
Table 88. Nanobiotix(France) NanoBioTechnology (NBT) Product
Table 89. Nanobiotix(France) Revenue in NanoBioTechnology (NBT) Business (2020-2025) & (US$ Million)
Table 90. Nanobiotix(France) Recent Development
Table 91. Dabur Pharma (India) Company Details
Table 92. Dabur Pharma (India) Business Overview
Table 93. Dabur Pharma (India) NanoBioTechnology (NBT) Product
Table 94. Dabur Pharma (India) Revenue in NanoBioTechnology (NBT) Business (2020-2025) & (US$ Million)
Table 95. Dabur Pharma (India) Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. NanoBioTechnology (NBT) Picture
Figure 2. Global NanoBioTechnology (NBT) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global NanoBioTechnology (NBT) Market Share by Type: 2024 VS 2031
Figure 4. 0-10 nm Features
Figure 5. 10-100 nm Features
Figure 6. Global NanoBioTechnology (NBT) Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global NanoBioTechnology (NBT) Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceuticals Case Studies
Figure 9. Medical Research Case Studies
Figure 10. Food and Agriculture Case Studies
Figure 11. Others Case Studies
Figure 12. NanoBioTechnology (NBT) Report Years Considered
Figure 13. Global NanoBioTechnology (NBT) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global NanoBioTechnology (NBT) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global NanoBioTechnology (NBT) Market Share by Region: 2024 VS 2031
Figure 16. Global NanoBioTechnology (NBT) Market Share by Players in 2024
Figure 17. Global Top NanoBioTechnology (NBT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NanoBioTechnology (NBT) as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by NanoBioTechnology (NBT) Revenue in 2024
Figure 19. North America NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America NanoBioTechnology (NBT) Market Share by Country (2020-2031)
Figure 21. United States NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe NanoBioTechnology (NBT) Market Share by Country (2020-2031)
Figure 25. Germany NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific NanoBioTechnology (NBT) Market Share by Region (2020-2031)
Figure 33. China NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America NanoBioTechnology (NBT) Market Share by Country (2020-2031)
Figure 41. Mexico NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa NanoBioTechnology (NBT) Market Share by Country (2020-2031)
Figure 45. Turkey NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Ablynx (Belgium) Revenue Growth Rate in NanoBioTechnology (NBT) Business (2020-2025)
Figure 49. Nami Therapeutics (US) Revenue Growth Rate in NanoBioTechnology (NBT) Business (2020-2025)
Figure 50. Celgene Corporation (US) Revenue Growth Rate in NanoBioTechnology (NBT) Business (2020-2025)
Figure 51. Nanophase Technologies Corporation (US) Revenue Growth Rate in NanoBioTechnology (NBT) Business (2020-2025)
Figure 52. Sigma-Aldrich (US) Revenue Growth Rate in NanoBioTechnology (NBT) Business (2020-2025)
Figure 53. SkyePharma Pharmaceuticals (France) Revenue Growth Rate in NanoBioTechnology (NBT) Business (2020-2025)
Figure 54. Nano Bridging Molecules SA (Switzerland) Revenue Growth Rate in NanoBioTechnology (NBT) Business (2020-2025)
Figure 55. XanTecbioanalytics GmbH (Germany) Revenue Growth Rate in NanoBioTechnology (NBT) Business (2020-2025)
Figure 56. Nanobiotix(France) Revenue Growth Rate in NanoBioTechnology (NBT) Business (2020-2025)
Figure 57. Dabur Pharma (India) Revenue Growth Rate in NanoBioTechnology (NBT) Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global NanoBioTechnology (NBT) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of 0-10 nm
Table 3. Key Players of 10-100 nm
Table 4. Global NanoBioTechnology (NBT) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global NanoBioTechnology (NBT) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global NanoBioTechnology (NBT) Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global NanoBioTechnology (NBT) Market Share by Region (2020-2025)
Table 8. Global NanoBioTechnology (NBT) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global NanoBioTechnology (NBT) Market Share by Region (2026-2031)
Table 10. NanoBioTechnology (NBT) Market Trends
Table 11. NanoBioTechnology (NBT) Market Drivers
Table 12. NanoBioTechnology (NBT) Market Challenges
Table 13. NanoBioTechnology (NBT) Market Restraints
Table 14. Global NanoBioTechnology (NBT) Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global NanoBioTechnology (NBT) Market Share by Players (2020-2025)
Table 16. Global Top NanoBioTechnology (NBT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NanoBioTechnology (NBT) as of 2024)
Table 17. Ranking of Global Top NanoBioTechnology (NBT) Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by NanoBioTechnology (NBT) Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of NanoBioTechnology (NBT), Headquarters and Area Served
Table 20. Global Key Players of NanoBioTechnology (NBT), Product and Application
Table 21. Global Key Players of NanoBioTechnology (NBT), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global NanoBioTechnology (NBT) Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global NanoBioTechnology (NBT) Revenue Market Share by Type (2020-2025)
Table 25. Global NanoBioTechnology (NBT) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global NanoBioTechnology (NBT) Revenue Market Share by Type (2026-2031)
Table 27. Global NanoBioTechnology (NBT) Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global NanoBioTechnology (NBT) Revenue Market Share by Application (2020-2025)
Table 29. Global NanoBioTechnology (NBT) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global NanoBioTechnology (NBT) Revenue Market Share by Application (2026-2031)
Table 31. North America NanoBioTechnology (NBT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America NanoBioTechnology (NBT) Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America NanoBioTechnology (NBT) Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe NanoBioTechnology (NBT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe NanoBioTechnology (NBT) Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe NanoBioTechnology (NBT) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific NanoBioTechnology (NBT) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific NanoBioTechnology (NBT) Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific NanoBioTechnology (NBT) Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America NanoBioTechnology (NBT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America NanoBioTechnology (NBT) Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America NanoBioTechnology (NBT) Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa NanoBioTechnology (NBT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa NanoBioTechnology (NBT) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa NanoBioTechnology (NBT) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Ablynx (Belgium) Company Details
Table 47. Ablynx (Belgium) Business Overview
Table 48. Ablynx (Belgium) NanoBioTechnology (NBT) Product
Table 49. Ablynx (Belgium) Revenue in NanoBioTechnology (NBT) Business (2020-2025) & (US$ Million)
Table 50. Ablynx (Belgium) Recent Development
Table 51. Nami Therapeutics (US) Company Details
Table 52. Nami Therapeutics (US) Business Overview
Table 53. Nami Therapeutics (US) NanoBioTechnology (NBT) Product
Table 54. Nami Therapeutics (US) Revenue in NanoBioTechnology (NBT) Business (2020-2025) & (US$ Million)
Table 55. Nami Therapeutics (US) Recent Development
Table 56. Celgene Corporation (US) Company Details
Table 57. Celgene Corporation (US) Business Overview
Table 58. Celgene Corporation (US) NanoBioTechnology (NBT) Product
Table 59. Celgene Corporation (US) Revenue in NanoBioTechnology (NBT) Business (2020-2025) & (US$ Million)
Table 60. Celgene Corporation (US) Recent Development
Table 61. Nanophase Technologies Corporation (US) Company Details
Table 62. Nanophase Technologies Corporation (US) Business Overview
Table 63. Nanophase Technologies Corporation (US) NanoBioTechnology (NBT) Product
Table 64. Nanophase Technologies Corporation (US) Revenue in NanoBioTechnology (NBT) Business (2020-2025) & (US$ Million)
Table 65. Nanophase Technologies Corporation (US) Recent Development
Table 66. Sigma-Aldrich (US) Company Details
Table 67. Sigma-Aldrich (US) Business Overview
Table 68. Sigma-Aldrich (US) NanoBioTechnology (NBT) Product
Table 69. Sigma-Aldrich (US) Revenue in NanoBioTechnology (NBT) Business (2020-2025) & (US$ Million)
Table 70. Sigma-Aldrich (US) Recent Development
Table 71. SkyePharma Pharmaceuticals (France) Company Details
Table 72. SkyePharma Pharmaceuticals (France) Business Overview
Table 73. SkyePharma Pharmaceuticals (France) NanoBioTechnology (NBT) Product
Table 74. SkyePharma Pharmaceuticals (France) Revenue in NanoBioTechnology (NBT) Business (2020-2025) & (US$ Million)
Table 75. SkyePharma Pharmaceuticals (France) Recent Development
Table 76. Nano Bridging Molecules SA (Switzerland) Company Details
Table 77. Nano Bridging Molecules SA (Switzerland) Business Overview
Table 78. Nano Bridging Molecules SA (Switzerland) NanoBioTechnology (NBT) Product
Table 79. Nano Bridging Molecules SA (Switzerland) Revenue in NanoBioTechnology (NBT) Business (2020-2025) & (US$ Million)
Table 80. Nano Bridging Molecules SA (Switzerland) Recent Development
Table 81. XanTecbioanalytics GmbH (Germany) Company Details
Table 82. XanTecbioanalytics GmbH (Germany) Business Overview
Table 83. XanTecbioanalytics GmbH (Germany) NanoBioTechnology (NBT) Product
Table 84. XanTecbioanalytics GmbH (Germany) Revenue in NanoBioTechnology (NBT) Business (2020-2025) & (US$ Million)
Table 85. XanTecbioanalytics GmbH (Germany) Recent Development
Table 86. Nanobiotix(France) Company Details
Table 87. Nanobiotix(France) Business Overview
Table 88. Nanobiotix(France) NanoBioTechnology (NBT) Product
Table 89. Nanobiotix(France) Revenue in NanoBioTechnology (NBT) Business (2020-2025) & (US$ Million)
Table 90. Nanobiotix(France) Recent Development
Table 91. Dabur Pharma (India) Company Details
Table 92. Dabur Pharma (India) Business Overview
Table 93. Dabur Pharma (India) NanoBioTechnology (NBT) Product
Table 94. Dabur Pharma (India) Revenue in NanoBioTechnology (NBT) Business (2020-2025) & (US$ Million)
Table 95. Dabur Pharma (India) Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. NanoBioTechnology (NBT) Picture
Figure 2. Global NanoBioTechnology (NBT) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global NanoBioTechnology (NBT) Market Share by Type: 2024 VS 2031
Figure 4. 0-10 nm Features
Figure 5. 10-100 nm Features
Figure 6. Global NanoBioTechnology (NBT) Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global NanoBioTechnology (NBT) Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceuticals Case Studies
Figure 9. Medical Research Case Studies
Figure 10. Food and Agriculture Case Studies
Figure 11. Others Case Studies
Figure 12. NanoBioTechnology (NBT) Report Years Considered
Figure 13. Global NanoBioTechnology (NBT) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global NanoBioTechnology (NBT) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global NanoBioTechnology (NBT) Market Share by Region: 2024 VS 2031
Figure 16. Global NanoBioTechnology (NBT) Market Share by Players in 2024
Figure 17. Global Top NanoBioTechnology (NBT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NanoBioTechnology (NBT) as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by NanoBioTechnology (NBT) Revenue in 2024
Figure 19. North America NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America NanoBioTechnology (NBT) Market Share by Country (2020-2031)
Figure 21. United States NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe NanoBioTechnology (NBT) Market Share by Country (2020-2031)
Figure 25. Germany NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific NanoBioTechnology (NBT) Market Share by Region (2020-2031)
Figure 33. China NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America NanoBioTechnology (NBT) Market Share by Country (2020-2031)
Figure 41. Mexico NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa NanoBioTechnology (NBT) Market Share by Country (2020-2031)
Figure 45. Turkey NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE NanoBioTechnology (NBT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Ablynx (Belgium) Revenue Growth Rate in NanoBioTechnology (NBT) Business (2020-2025)
Figure 49. Nami Therapeutics (US) Revenue Growth Rate in NanoBioTechnology (NBT) Business (2020-2025)
Figure 50. Celgene Corporation (US) Revenue Growth Rate in NanoBioTechnology (NBT) Business (2020-2025)
Figure 51. Nanophase Technologies Corporation (US) Revenue Growth Rate in NanoBioTechnology (NBT) Business (2020-2025)
Figure 52. Sigma-Aldrich (US) Revenue Growth Rate in NanoBioTechnology (NBT) Business (2020-2025)
Figure 53. SkyePharma Pharmaceuticals (France) Revenue Growth Rate in NanoBioTechnology (NBT) Business (2020-2025)
Figure 54. Nano Bridging Molecules SA (Switzerland) Revenue Growth Rate in NanoBioTechnology (NBT) Business (2020-2025)
Figure 55. XanTecbioanalytics GmbH (Germany) Revenue Growth Rate in NanoBioTechnology (NBT) Business (2020-2025)
Figure 56. Nanobiotix(France) Revenue Growth Rate in NanoBioTechnology (NBT) Business (2020-2025)
Figure 57. Dabur Pharma (India) Revenue Growth Rate in NanoBioTechnology (NBT) Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232